Q32 Bio Inc.
QTTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | -$7 | $7 | $34 |
| % Growth | 100% | -200% | -80.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $10 |
| Gross Profit | -$0 | -$7 | $7 | $24 |
| % Margin | – | 100% | 100% | 71.9% |
| R&D Expenses | $48 | $32 | $36 | $93 |
| G&A Expenses | $0 | $10 | $10 | $0 |
| SG&A Expenses | $17 | $10 | $10 | $27 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $66 | $42 | $46 | $120 |
| Operating Income | -$66 | -$48 | -$39 | -$96 |
| % Margin | – | 725.5% | -589.8% | -282.4% |
| Other Income/Exp. Net | $18 | -$5 | -$4 | $0 |
| Pre-Tax Income | -$48 | -$53 | -$43 | -$96 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$48 | -$54 | -$43 | -$96 |
| % Margin | – | 808% | -643.6% | -281.9% |
| EPS | -5.12 | -16.7 | -13.42 | -12.23 |
| % Growth | 69.3% | -24.4% | -9.7% | – |
| EPS Diluted | -6.58 | -16.7 | -13.42 | -12.23 |
| Weighted Avg Shares Out | 12 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 12 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $10 |
| EBITDA | -$45 | -$48 | -$39 | -$86 |
| % Margin | – | 718% | -584.2% | -253.8% |